Catatan episode
Every fifth patient you anesthetize has diabetes, and the medications they're on are no longer just a pre-op checkbox. In this podcast, we dissect the latest evidence: why GLP-1 agonists may be safer to continue than to stop, what the SGLT-2 data is really telling us, and the shift toward highly personalized, evidence-based risk assessments..
Read more about this topic HERE.
======================================
Where else to find us:
Web - https://www.nysora.com/
Instagram - instagram.com/nysora.inc/
LinkedIn…
Situs: podcasters.spotify.com

